Julie and Larry share their experience of LDN for Parkinson’s Disease (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dan shares his Parkinson’s story - 31st Jan 2018 (LDN, low dose naltrexone) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dan from the United States shares his Parkinson’s and LDN story on the LDN Radio Show with Linda Elsegod.

Sam - US: Parkinson’s, 31 Jan 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.